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Abstract  
Averrhoa carambola L. (Oxalidaceae), commonly known as star fruit bears a great significance in traditional medicine. Traditionally, A. carambola was used 
in ailments such as arthralgia, chronic headache, boils and pyodermas, colds, cough, epistaxis, spermatorrhea, fever, food poisoning, gastroenteritis, malaria, 
malarial splenomegaly, oliguria, postpartum edema, sore throat, subcalorism and traumatic injury. Pharmacological investigations on A. carambola have 
demonstrated anti-inflammatory, antimicrobial, antifungal, antitumor and anti-ulcer activities. In addition, the plant possesses hypocholesterolemic, 
hypoglycemic, hypotensive, nephrotoxic, neurotoxic, negative inotropic and chronotropic effects. Phytochemical investigations have shown the presence of 
saponins, tannins, alkaloids and flavonoids. This review is an effort to update the pharmacological activities and clinical studies on A. carambola. 
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Resumen 
Averrhoa carambola L. (Familia: Oxalidaceae), comúnmente conocida como fruta de la estrella tiene una gran importancia en la medicina tradicional. La 
Medicina Tradicional reporta el uso de A. carambola en dolencias tales como: artralgia, dolor de cabeza crónico, forúnculos y piodermas, resfriados, tos, 
epistaxis, espermatorrea, fiebre,  intoxicación alimentaria, gastroenteritis, malaria, paludismo, esplenomegalia malárica, oliguria, edema post-parto, dolor de 
garganta , subcalorismo y lesiones traumáticas. Investigaciones farmacológicas en A. carambola han demostrado efectos anti-inflamatorios, antimicrobianos, 
antitumorales, antifúngicas, y actividades anti-úlcera, hipocolesterolémico, hipoglucemiante, hipotensor, nefrotóxicos, y efectosneurotóxicos  y cronotrópicos 
negativos.  Proyecciones preliminares fitoquímicas han demostrado la presencia de saponinas, taninos, alcaloides y flavonoides. Esta revisión constituye un 
esfuerzo para actualizar las actividades farmacológicas y estudios clínicos sobre A. carambola.  
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INTRODUCTION: 
Star fruit, Averrhoa carambola (Oxalidaceae) is found 
in America, Brazil, Australia, South-East Asia 
including Malaysia, Southern China, Taiwan and 
India. A. carambola tree is usually 3 to 5 m in height 
and can reach a maximum height of 10 m, with a 
finely fissured light brown bark and 15 to 20 cm long 
leaves. It  bears large indehiscent yellowish-green  
berry fruit of 5 to 8 cm long with a characteristic shape 
resembling a five pointed star, and each cell of the 
fruit contains five arillate seeds (Morton, 1987; 
Margen, 1992).  
In traditional medicine, the fruit was used for 
treating ailments such as cough, food poisoning, sore 
throat and malarial splenomegaly; the root for treating 
arthralgia, chronic headache, epistaxis and 
spermatorrhea; the leaves for treating boils, colds, 
gastroenteritis, oliguria, postpartum edema, pyodermas 
and traumatic injury, while the flowers for treating 
fever, malaria and subcalorism (Sung et al., 1998). 
There are previous reviews on A. carambola 
describing mainly the botanical and cultivation 
aspects, traditional uses and some pharmacological 
activities (Avinash et al., 2012; Gheewala et al., 2012; 
Manda et al., 2012). In this review, we summarize and 
update the phytochemical, pharmacological and 
clinical investigations on A. carambola. 
 
PHARMACOLOGICAL PROPERTIES 
Antioxidant capacity 
Luximon-Ramma et al, (2003) examined the 
antioxidant capacity, total phenolics, 
proanthocyanidins, flavonoids and vitamin C contents 
of 17 commonly consumed exotic fruits from 
Mauritius including A. carambola . The antioxidant 
activities of  A. carambola were found to be ranged 
from 11 to 17 μmol Trolox equivalent antioxidant 
capacity (TEAC)/g fresh weight, and 9 to 22 μmol 
ferric reducing antioxidant power (FRAP)/g fresh 
weight, for the acid and sweet fruits respectively. The 
total phenolics content was 1429 and 2099 μg/g fresh 
weight; proanthocyanidins 896 and 1321 μg/g fresh 
weight; total flavonoids 103 and 148 μg/g fresh weight 
and vitamin C content was 190 and 144 μg/g fresh 
weight, for the acid and sweet fruits respectively. 
There were strong correlations between antioxidant 
activity (assessed by both TEAC and FRAP) and total 
phenolics and proanthocyanidins contents. Flavonoids 
seemed to contribute less to the antioxidant potential 
of the fruit, while very poor correlation was observed 
between ascorbate content and antioxidant activity. 
The antioxidant capacity of A. carambola was found 
to be among the highest in the study group and the 
study concluded A. carambola to be a substantial 
source of phenolic antioxidants, thus it may exhibit 
potent health benefits. 
Shui and Leong, (2006) showed that the 
residue of A. carambola  fruit, which is normally 
discarded during juice drink processing, contains 
much higher antioxidant activity than the extracted 
juice using various methods for assessing antioxidant 
activity. Under optimized extraction conditions, the 
residue accounted for around 70% of total antioxidant 
activity and total polyphenolic contents, however it 
only contributed 15% of the weight of the whole fruit. 
Freeze-dried residue-powder, which accounted for 
around 5% of total weight, had total polyphenolic 
content of 33.2 ± 3.6 mg gallic acid equivalent 
(GAE)/g sample, total antioxidant activity of 3490 ± 
310 and 3412 ± 290 mg L-ascorbic acid equivalent 
antioxidant capacity or 5270 ± 468 and 5152 ± 706 mg 
trolox equivalent antioxidant capacity per 100 g 
sample obtained by 2,2′-azino-bis-(3-
ethylbenzthiazoline-6-sulfonic acid) free radical and 
1,1-diphenyl-2-picryl-hydrazyl scavenging assays, 
respectively. It was also found to have 510.3 ± 68.1 
mol ferric reducing/antioxidant power per gram 
sample. The residue-extract also shows strong 
antioxidant activity in delaying oxidative rancidity of 
soya bean oil at 110 °C. Antioxidant activity and 
polyphenolic profile of residue extracts were 
compared with extracts of standardized pyconogenol. 
High performance liquid chromatography coupled 
with mass spectrometry revealed that major 
proanthocyanidins in A. carambola fruit were different 
from their isomers in the standardised extracts of 
pyconogenol. The high content of phenolics and strong 
antioxidant activity of residue extract indicate that the 
residue powder may yield health benefits when used in 
functional food products and that residue extract 
should also be regarded as potential source of nutrients 
in future. 
Ali et al., (2011) screened 20 different kinds 
of fruits including A. carambola  from Aizawal 
Market of Mizoram India for their antioxidant 
potential using DPPH, FRAP and total phenolics 
content assay. A. carambola showed moderate 
antioxidant activity among the tested fruits, the 
activity was found to be 81.03 ± 1.97 g of Trolox 
equivalent/100 g of fruit (DPPH assay),  78.770 ± 0.33 
g of Trolox equivalent/100 g of fruit (FRAP assay) 
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and total phenolics contents were found to be 54.45 ± 
0.43 g of gallic acid equivalent/100 g of fruit. 
Moresco et al., (2012) reported isolation of β-
sitosterol from the n-hexane fraction; apigenin-6-C-β-
L-fucopyranoside and apigenin6-C-(2"-O-α-L-
rhamnopyranosyl)-β-L-fucopyranoside from the ethyl 
acetate fraction, and a new compound apigenin6-C-
(2"-O-α-L-rhamnopyranosyl)-β-D-glucopyranoside 
from the n-butanol fraction. The antioxidant potential 
of the fractions was examined using the DPPH radical 
scavenging assay and reducing power of iron (III) to 
iron (II) ions. The ethyl acetate and n-butanol fractions 
showed the highest antioxidant potential to scavenge 
DPPH, with the IC50 values of 90.92 and 124.48 
µg/mL, respectively. In the assay of reducing power, 
these fractions presented 135.64 and 125.12 mg/g of 
ascorbic acid equivalents, respectively. The 
antioxidant activity exhibited a significant correlation 
with the phenolic content (r
2 
= 0.997), but a poor 
correlation with the flavonoids content (r
2 
= 0.424). 
The n-hexane fraction was the only fraction to show 
toxicity on A. salina with LC50 of 800.2 µg/mL. 
 
Anti-inflammatory activity 
Cabrini et al., (2011) examined the ethanol extract of 
A. carambola leaves, its hexane, ethyl acetate and 
butanol fractions and two isolated flavonoids, 
apigenin-6-C-β-l-fucopyranoside and apigenin-6-C-
(2″-O-α-l-rhamnopyranosyl)-β-l-fucopyranoside for 
anti-inflammatory activity. The ethanol extract 
reduced edema in a dose-dependent manner, resulting 
in a maximum inhibition of 73 ± 3% and an ID50 value 
of 0.05 (range: 0.02–0.13) mg/ear. Myeloperoxidase 
activity was also inhibited by the ethanol extract, 
resulting in a maximum inhibition of 60 ± 6% (0.6 
mg/ear). The tested fractions inhibited edema 
formation and myeloperoxidase activity, the ethyl 
acetate fraction was the most effective fraction, 
resulting in inhibition levels of 75 ± 5 and 54 ± 8% for 
edema formation and myeloperoxidase activity, 
respectively. However, the isolated compounds did not 
show any substantial anti-inflammatory activity. 
 
Acetylcholinesterase inhibitory activity 
Teh et al., (2010) investigated the effects of A. 
carambola  juice kept at different storage conditions 
on the activity of acetylcholinesterase in various 
organs of Sprague Dawley (SD) rats. Three groups (5 
animals per group) of rats were administered with 
distilled water, and different star fruit preparations, 
freshly prepared star fruit juice and after 3 hours 
storage, respectively. The results showed a substantial 
decrease in the hepatic acetylcholinesterase activity in 
rats treated with star fruit juice highest activity was 
observed for the freshly prepared juice. 
 
Antimicrobial and antifungal activity 
Mia et al., (2007) isolated two compounds p-
anisaldehyde and β-sitosterol from the bark of A. 
carambola. The petroleum ether, carbon tetrachloride 
and chloroform fractions of the methanol extract of A. 
carambola when subjected to antimicrobial screening 
at 400 μg/disc demonstrated mild inhibition on 
microbial growth. The average zone of inhibition 
produced by the petroleum ether, carbon tetrachloride 
and chloroform soluble fractions were 8-12 mm, 8-12 
mm, and 8-15 mm, respectively. The petroleum ether 
extract moderately inhibited the growth of E. coli and 
S. dysenteriae having the zone of inhibition of 12 mm 
each.  On the other hand, the chloroform soluble 
fraction strongly inhibited the growth of E. coli with 
zone of inhibition 15 mm. In the case of fungi, mild 
inhibitory activity was exhibited by all extractives. 
The LC50 values obtained from cytotoxicity evaluation 
were 0.32, 0.70, 0.06 and 3.14 μg/mL for standard 
vincristine sulfate, petroleum ether, carbon 
tetrachloride and chloroform soluble fractions, 
respectively. 
 
Antitumor activity 
Li et al., (2012) studied the biotransformation of 
dihydro-epi-deoxyarteannuin B by using suspension-
cultured cells of A. carambola. One novel 
sesquiterpene, 7α-hydroxy-dihydro-epideoxyarte-
annuin B, and one known sesquiterpene, 3-α-hydroxy-
dihydro-epideoxyarteannuin B, were obtained upon 
the addition of dihydro-epi-deoxyarteannuin B. The 
study concluded that, cultured cells of A. carambola 
have the capacity to hydroxylate sesquiterpene 
compounds in a regio- and stereoselective manner. 
The inhibitory effects of 7α-hydroxy-dihydro-
epideoxyarteannuin B and 3-α-hydroxy-dihydro-
epideoxyarteannuin B on proliferation of K562 and 
HeLa cell lines were (59.29 ± 0.99, 84.04 ± 0.27 
µmol/mL) and (40.63 ± 1.45, 41.54 ± 0.82 µmol/mL) , 
respectively. 
 
Anti-ulcer activity 
Goncalves et al., (2006) examined the water-alcohol 
extract of leaves of A. carambola for its anti-
ulcerogenic potential. The ethanolic extract at doses of 
800 and 1200 mg/kg p.o., only showed significant 
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anti-ulcer activity in the acidified-ethanol-induced 
ulcer model in rats. However, the extract did not show 
any activity in the indomethacin and acute stress 
ulcerogenic models. Thus, the study concluded 
ethanolic extract of A. carambola as having low anti-
ulcer activity. 
 
Negative inotropic and chronotropic effect 
Vasconcelos et al., (2005) examined the atrial 
isometric force in stimulated left atria and determined 
the chronotropic changes in spontaneously beating 
right atria. A. carambola leaves extracts (1.5 mg/mL) 
abolished the contractile force in a concentration-
dependent manner in cardiac contractility in the 
guinea-pig atria. Among the methanolic, ethanolic, 
aqueous, and acetic acid extracts, the aqueous extract 
was found to be the most potent (EC50 = 520 ± 94 
µg/mL). The aqueous extract abolished the positive 
Bowditch staircase phenomenon and reduced the 
inotropic response to CaCl2, events that are dependent 
on the cellular Ca
2+ 
inward current. In spontaneously 
beating atria, the aqueous extract promoted a negative 
chronotropic effect that was antagonized by 0.1 µM 
isoproterenol bitartrate. The EC50 of the aqueous 
extract increased from 133 ± 58 to 650 ± 100 µg/mL 
in the presence of this agonist.  
Subsequently, Vasconcelos et al., (2008) 
investigated the effects of the aqueous extract of A. 
carambola leaves on the cellular calcium influx by 
examining the left atrium of guinea pig and the 
pituitary GH3 cells. In the atrium, the aqueous extract 
(1500 µg/mL) shifted to the right the concentration-
effect curve of the positive inotropic effect produced 
by (±) BAY K 8644, an L-type calcium channel 
agonist. The aqueous extract increased 
EC50 (concentration required to promote 50% of the 
maximum effect) of the inotropic effect of BAY K 
8644 from 7.8 ± 0.38 to 115.1 ± 0.44 nM. In GH3 cells 
treated with 500 µg/mL of aqueous extract, the L-type 
calcium inward current declined by 30%. The extract 
did not change the voltage correspondent to the peak 
current. It was suggested that, at least in part, the 
negative inotropic effect of aqueous extract on the 
guinea pig atrium is due to a reduction of the L-type 
calcium current. 
 
Electrophysiological effects 
Vasconcelos et al., (2006) examined the effects of the 
aqueous extract of A. carambola leaves on guinea pig 
heart. In this study, the aqueous extract induced many 
kinds of atrioventricular blocks (1st, 2nd, and 3rd 
degrees); depressed the cardiac rate from 136 ± 17 to 
89 ± 14 bpm, increased the QRS complex duration 
from 27 ± 3.1 to 59 ± 11 ms and increased the QT 
interval from 229 ± 23 to 264 ± 19 ms. Additionally, it 
increased the conduction time between the right atrium 
and the His bundle (27 ± 6.5%), reduced the 
intraventricular pressure (86 ± 6%) and decreased the 
conduction velocity of atrial impulse (17 ± 3%). 
However, the conduction time from the His bundle to 
the right ventricle was not altered. Atropine sulfate did 
not change either the electrocardiographic parameters 
or the intraventricular pressure effects promoted by the 
A. carambola aqueous extract. Thus, the study 
suggested avoiding the use of such extracts since it can 
induce electrical and mechanical changes in the 
normal heart. 
 
Hypotensive activity 
Soncini et al., (2011) studied the hypotensive effect of 
the aqueous extract of A. carambola  and its 
underlying mechanisms using isolated rat aorta. In 
vitro, the aqueous extract caused a reduction in the 
Emax response to phenylephrine without a change in 
sensibility. Furthermore, in a depolarized Ca
2+
-free 
medium, the aqueous extract inhibited CaCl2-induced 
contractions and caused a concentration-dependent 
rightward shift of the response curves, suggesting that 
the aqueous extract inhibited the contractile 
mechanisms involving extracellular Ca
2+
 influx. The 
study concluded the aqueous extract to be hypotensive 
in nature and suggested the effects to be in part, due to 
the inhibition of Ca
2+
, which is in agreement with its 
uses in traditional medicine. 
 
Hypocholesterolemic activity 
Wu et al., (2009) examined the potential 
hypocholesterolemic activity of different insoluble 
fibers prepared from A. carambola with or without 
micronization processing. After micronization, the 
cation-exchange and water-holding capacities of the A. 
carambola pectic polysaccharide-rich insoluble fibres 
were effectively increased from 8.5 to 22.4 mL/g. The 
A. carambola microsized insoluble fibers reduced the 
concentrations of serum triglyceride by and total 
cholesterol by 15.6% and 15.7%, respectively by 
means of enhancing the excretion of cholesterol and 
bile acids in the feces. The study suggests a new 
approach of micronization of the fruit which may help 
to improve physiological functions of food fibers in 
fiber-rich functional food applications. The study also 
indicates that the particle size is an important factor in 
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affecting the characteristics and physiological 
functions of insoluble fibers.  
 
Hypoglycaemic activity 
Ferreira et al., (2008) examined the effects of the 
hydroalcoholic extract of leaves of A. carambola  L. 
on fasting blood glucose. The hydroalcoholic extract 
treated animals showed significantly lower fasting 
blood glucose (p < 0.05). In contrast, livers from 
hydroalcoholic extract of these animals showed 
significantly higher (p < 0.05) glucose production 
from L-alanine. This effect was mediated, at least part 
of it, by an activation of the catabolism of L-alanine 
inferred by the increased hepatic urea and L-lactate 
production. Unlike L-alanine, the glucose production 
from L-glutamine, L-lactate and glycerol was not 
affected by the treatment. Likewise, the 
hydroalcoholic extract treatment did not affect the 
glucose uptake in soleus muscles, inferred by the 
incorporation of [
14
C]-glucose to glycogen (glycogen 
synthesis) and [
14
C]-lactate production. Thus, the 
study suggests that reduction of fasting blood glucose 
promoted by the treatment with hydroalcoholic extract 
of A. carambola was not mediated by an inhibition of 
hepatic gluconeogenesis and/or an increased glucose 
uptake by muscles. 
Chau et al., (2004b) investigated the 
hypoglycaemic effects of several insoluble fiber-rich 
fractions including insoluble dietary fiber, alcohol-
insoluble solid and water-insoluble solid obtained 
from the pomace of A. carambola , by some in vitro 
methods. It was found that the three insoluble fiber-
rich fractions could effectively adsorb glucose, retard 
glucose diffusion, postpone the release of glucose 
from starch, and inhibit the activity of α-amylase to 
different extents. The hypoglycemic effects of these 
insoluble fiber-rich fractions were significantly (P < 
0.05) stronger than that of cellulose. Thus, it was 
concluded that these fiber-rich fractions could be 
incorporated as low-calorie bulk ingredients in high-
fiber foods to reduce calorie level and assist the 
control of blood glucose level. 
 
Nephrotoxic effect 
Neto et al., (2009) studied the effects of A. carambola  
fruit on patients with renal failure, who are not yet on 
dialysis and concluded that the fruit and its juice 
induces nephrotoxicity and neurotoxicity, which may 
sometimes be fatal. Patients with chronic kidney 
disease (stages 3–5 but not on dialysis) should be 
prohibited from eating the fruit. People with normal 
renal function must also be warned to avoid ingestion 
of large amounts of the fruit or juice especially on an 
empty stomach. 
 
Neurotoxic effect 
Carolino et al., (2005) examined the effects of a 
neurotoxic fraction isolated from A. carambola  on 
GABAergic and glutamatergic transmission systems. 
The fraction was obtained by sequential 
chromatography of the aqueous extract on anion 
exchange column, then on cation exchange column 
and, finally on reversed-phase high performance liquid 
chromatography (HPLC). The fraction did not affect 
GABA/glutamate uptake or release, or on glutamate 
binding, but effected GABA binding in a 
concentration-dependent manner (IC50 0.89 mM). 
Video-electroencephalogram recordings showed that 
cortical administration of neurotoxic fraction, induced 
behavioral changes in animals, including tonic-clonic 
seizures, evolving into status epilepticus, accompanied 
by cortical epileptiform activity. The neurotoxic 
fraction has not yet been chemically characterized but 
the preliminary data suggested that it contains a non 
peptide molecule differing from oxalic acid and 
bearing a molecular weight less than 500. 
 
PHYTOCHEMISTRY:  
Chemical constituents isolated from A. carambola 
Averrhoa carambola has been the subject of 
phytochemical studies since late 1970s. The following 
are the chemical constituents isolated for A. 
carambola. 
O
O
OH
OHHO
HO
OH
OH
O
O
OHOH
OH
Apigenin-6-C-(2 -O-α -L-rhamnopyranosyl)-β-L-
fucopyranoside (Araho et al., 2005) 
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O
OOH
HO
OH
O
Me
OH
HO
OH
  
Apigenin-6-C-β-L-fucopyranoside (Araho et al., 
2005) 
 
O
OOH
HO
OH
O
O
HO
HO
OH
OH
HOHO
HOH2C
       
Apigenin- 6-C-(2”-O-α-L-rhamnopyranosyl)-β-D-
glucopyranoside (Henrique et al., 2011) 
 
O H
OCH3 
P-Anisaldehyde (Mia et al., 2007) 
 
 
 
O OH
HO
OH
OH
 
 
Gallic acid (Guanghou and Lai, 2004) 
 
HO
OH
OH
OH
O
O
HO
OH
HO
 
Quercetin-O-β-D-glucoside (Tiwari et al.,1979) 
 
O
O
HO
OH O
HO
HO
OH
OH
OH
O
 
 
Quercetin-3-O- rhamonoside (Nina et al., 2006) 
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HO
H
H
 
β-amirin (Tadros et al., 2004) 
 
HO
H
 
β-sitosterol (Ranganayaki et al., 1980) 
 
 
HO
H
H
 
 
 
Lupeol (Ranganayaki et al., 1980) 
O+
O
O
OH
OH
HO
OH
O
OH
OH
OH
HO
 
Cyanidin 3-O-β- D- glucoside  
(Gunasegaran, 1992) 
 
O+
O
O
OH
OH
HO
OH
O
OH
OH
OH
HO
Cl-
 
 
Cyanidin-3, 5-O-β-D-Diglucoside 
(Gunasegaran, 1992) 
 
HO
OH
OH
OH
HO
 
(−) Epicatechin (Guanghou and Lai, 2004) 
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OHO
OH
OH
OH
OH
 
 
Proanthocyanidin (Guanghou and Lai,  2004) 
 
O
O
O
OH
OH
HO
OH O
O
O
OH
HO
OH
HO
HO OH  
Rutin (Tiwari et al., 1979) 
 
 
O
O
OH
HO
OH
HO
 
Vitamin C (Guanghou and Lai, 2004) 
 
C13-aroma compounds 
Herderich et al., (1992) reported identifications of 
glycosidically bound constituents from star fruit (A. 
carambola L.) using HRGC and HRGC-MS 
techniques. The constituents were obtained from the 
extracts by Amberlite XAD-2 adsorption followed by 
methanol elution. The compounds identified were the 
ionone derivatives, namely 4-hydroxy-β-ionol, 3-
hydroxy-β-ionol, 4-oxo-β-ionol, 3-hydroxy-β-ionone, 
3-oxo-α-ionol, 3-oxo-retro-α-ionol (2 isomers), 3-oxo-
4,5-dihydro-α-ionol, 3-oxo-7,8-dihydro-α-ionol 
(blumenol C), 3,5-dihydroxy-megastigma-6,7-diene-9-
one (grasshopper ketone), 3-hydroxy-β-damascone, 3-
hydroxy-5,6-epoxy-β-ionone, 3-hydroxy-5,6-epoxy-β-
ionol, 3,4-dihydro-3-hydroxyactinidol, vomifoliol 
(blumenol A), 4,5-dihydrovomifoliol and 7,8-
dihydrovomifoliol (Blumenol B). Several of these new 
constituents are easily degraded upon heat-treatment at 
natural pH condition of the fruit pulp, thus 
rationalizing the formation of a number of C13-aroma 
compounds, which have recently been reported as star 
fruit volatiles. 
 
β-Galactosidase 
Balasubramaniam et al., (2005) isolated β-
Galactosidase (EC. 3.2.1.23) from A. carambola  fruit 
and fractionated it using a combination of ion 
exchange and gel filtration chromatography into four 
isoforms, β-Galactosidase I, II, III and IV. The β-
galactosidases exhibited the molecular weights 84, 77, 
58 and 130 kDa, respectively. β-Galactosidase I, was 
the most prominent isoform.  The purified β-
galactosidase I was highly active in hydrolyzing (1 → 
4) β-linked spruce and a mixture of (1 → 3)β- and (1 
→ 6) β-linked gum arabic galactans. The β-
galactosidase I also exhibited the capacity to solubilize 
and depolymerize structurally intact pectins as well as 
to modify alkaline-soluble hemicelluloses, indicating 
in part changes that occur during ripening. 
 
Pharmacognostic and phytochemical analysis 
Thomas et al., (2008) conducted preliminary 
pharmacognostic and phytochemical analysis and 
showed the  presence of saponins, tannins, alkaloids 
and flavonoids. Furthermore, the study revealed that 
the water-soluble and alcohol soluble extractive values 
decreased gradually with ripening of fruit. 
 
Analysis of oxalic acid  
Wilson et al., (1982) quantified oxalic acid in 15 
Florida-grown A. carambola cultivars using simple 
and rapid high-performance liquid chromatographic 
(HPLC) method. Oxalic acid levels were found to vary 
among the cultivars examined from 0.08 to 0.73 g per 
100/g of fruit. 
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FRUIT AND FIBRE-RICH FRACTIONS 
COMPOSITIONS 
Fruit composition 
Narain et al., (2001) studied the composition of the 
fruit during maturation. The pH of the fruit increased 
with the advance in maturity, whereby the pH values 
were 3.44, 2.40 and 2.71 for ripe, green mature and 
half-ripe fruits, respectively. Increased calcium 
contents were observed at ripe stage (4.83 ± 0.27 
mg/100 g of edible fruit) and it was significantly 
different than the fruits at green mature (3.55 ± 0.85 
mg/100 g of edible fruit) or half-ripe stages (4.83 ± 
0.27 mg/100 g of edible fruit). The titratable acidity, 
reducing sugars and tannin contents of the fruits vary 
significantly among the fruits at different stages of 
maturity. 
 
Fiber-rich fractions 
Chau et al., (2004a) reported that the pomace of A. 
carambola  possess a high level of insoluble fiber-rich 
fractions including insoluble dietary fiber, alcohol-
insoluble solid, and water-insoluble solid (46.0–58.2 
g/100 g of pomace). These fiber-rich fractions were 
mostly composed of pectic substances and 
hemicellulose. The physicochemical properties of 
these fiber-rich fractions (water-holding capacities, 
swelling properties, and cation-exchange capacities) 
were significantly (P < 0.05) higher than those of 
cellulose. The capacity of these fiber-rich fractions to 
adsorb glucose and reduce amylase activity implied 
that they might help control postprandial serum 
glucose. Thus the study suggested that the 
consumption and application of the insoluble fiber-rich 
fractions as low-calorie bulk ingredients in fiber 
enrichment.  
 
CLINICAL STUDIES: 
Clinical symptoms and outcomes in uraemic patients 
given A. carambola 
Investigations of the clinical symptoms and outcomes 
of 32 uraemic patients ingesting star fruit showed that 
most common symptoms were persistent and 
intractable hiccups (in 30 patients; 93.75%), vomiting 
(in 22 patients; 68.7%), variable degrees of disturbed 
consciousness (mental confusion, psychomotor 
agitation; in 21 patients; 65.6%), decreased muscle 
power, limb numbness, paresis, insomnia and 
paresthesias (in 13 patients; 40.6%) and seizures (in 
seven patients; 21.8%). Patients who were promptly 
treated with hemodialysis, including those with severe 
intoxication, recovered without sequelae. The study 
concluded that hemodialysis, particularly on a daily 
basis, is the best treatment for star fruit intoxication. In 
adverse cases, continuous methods of replacement 
therapy may provide a superior initial procedure, since 
rebound effects are a common event. Peritoneal 
dialysis is of no use as a treatment, especially when 
consciousness disorders ensue (Neto et al., 2003). 
 
CONCLUSION 
A. carambola has long been used in traditional 
medicine and has demonstrated pharmacological 
activities which support its use in traditional uses as an 
important therapeutic agent. However, the scientific 
evidences are limited in respect to its bioactive 
constituents, bioavailability, pharmacokinetics, and 
therapeutic importance including clinical trials. Thus, 
future work on bioactivity-guided isolation of the 
active secondary metabolites responsible for the 
pharmacological activities of A. carambola, and 
studies on their structure-activity relationships, 
mechanisms of actions, pharmacokinetics and toxicity 
are required for the development of A. carambola as a 
therapeutic agent. Furthermore, the extracts or 
fractions with potential bioactivities may be 
standardized and employed in clinical studies. 
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